Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Virodhamine trifluoroacetate is an antagonist of endogenous cannabinoid receptor mixed that acts by being a full agonist at GPR55 and CB2 and partial antagonist at CB1.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Virodhamine trifluoroacetate is an antagonist of endogenous cannabinoid receptor mixed that acts by being a full agonist at GPR55 and CB2 and partial antagonist at CB1. |
Synonyms | Virodhamine-trifluoroacetate, Virodhamine trifluoroacetate salt |
Molecular Weight | 461.56 |
Formula | C24H38F3NO4 |
CAS No. | 1415264-56-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Virodhamine trifluoroacetate 1415264-56-0 Virodhamine-trifluoroacetate Virodhamine trifluoroacetate salt Virodhamine Trifluoroacetate inhibitor inhibit